BC006

DRUG2 trials

Sponsors

Dragonboat Biopharmaceutical Company Limited

Conditions

Advanced Solid Tumors (Including GCTTS)Idiopathic Pulmonary Fibrosis (IPF)

Phase 1

An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

Dragonboat Biopharmaceutical Company LimitedAdvanced Solid Tumors (Including GCTTS)

Start: 2021-11-26End: 2024-12-31Target: 90Updated: 2022-01-28

Phase 2

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

RecruitingNCT07447102

Dragonboat Biopharmaceutical Company LimitedIdiopathic Pulmonary Fibrosis (IPF)

Start: 2026-04-27End: 2029-04-01Target: 96Updated: 2026-05-13